Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
Author(s) -
Anne W.M. Lee,
W.H. Lau,
Stewart Y. Tung,
Daniel T. T. Chua,
Rick Chappell,
Ling Xu,
Lillian L. Siu,
W.M. Sze,
ToWai Leung,
Jonathan S. T. Sham,
Roger K.C. Ngan,
Stephen C.K. Law,
T.K. Yau,
Joseph S. K. Au,
Brian O’Sullivan,
E. Pang,
O S.K.,
Gordon K.�H. Au,
Joseph T. F. Lau
Publication year - 2005
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2004.00.7542
Subject(s) - medicine , nasopharyngeal carcinoma , randomized controlled trial , radiation therapy , cisplatin , oncology , chemoradiotherapy , chemotherapy , fluorouracil , gastroenterology , urology
This randomized study compared the results achieved by concurrent chemoradiotherapy (CRT) versus radiotherapy (RT) alone for nasopharyngeal carcinoma (NPC) with advanced nodal disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom